@yourmedmentor: A new ADHD medication is currently under FDA Priority Review, and it could be a meaningful option for adults and adolescents who have not found relief with existing treatments. Centanafadine is a first-in-class triple reuptake inhibitor. That means it targets three neurotransmitters at once — dopamine, norepinephrine, and serotonin. Most current ADHD medications focus only on the first two. Adding serotonin into the mix may make it especially relevant for ADHDers who also struggle with emotional dysregulation, overwhelm, and nervous system imbalance alongside the typical focus and attention symptoms. Centanafadine has completed successful Phase 3 trials and is now under Priority Review by the FDA, which suggests there is interest in expediting access to a new mechanism of action. This is news worth tracking. But remember — medication is one tool in the system. It works best when paired with the systems, environment, and lifestyle structures that support your nervous system as a whole. Follow and comment SYSTEMS to learn more about ADHD management — with or without medication. Save this and share it with someone who needs to hear it.

Dr. Heidi | Your Med Mentor

Open In TikTok:

Region: US

Wednesday 06 May 2026 22:37:39 GMT